Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (3463)

SortShow
Name Institution Why
Eric Paul Winer, M.D.Dana-Farber Cancer Institute Why?
Harold John Burstein, Ph.D., M.D.Dana-Farber Cancer Institute Why?
Richard David Gelber, Ph.D.Dana-Farber Cancer Institute Why?
Paul E. Goss, Ph.D., M.B.,B.Ch.Massachusetts General Hospital Why?
Ann Hart Partridge, M.D.Dana-Farber Cancer Institute Why?
Rachel Ann Freedman, M.D.Dana-Farber Cancer Institute Why?
Jeffrey A Meyerhardt, M.D.Dana-Farber Cancer Institute Why?
Joaquin Bellmunt Molins, M.D.Beth Israel Deaconess Medical Center Why?
Meredith M Regan, Sc.D.Dana-Farber Cancer Institute Why?
Guru Sonpavde, M.B.,B.S.Dana-Farber Cancer Institute Why?
Tari Ann King, M.D.Brigham and Women's Hospital Why?
Marcela Guadalupe del Carmen, M.D.Massachusetts General Hospital Why?
Nancy U. Lin, M.D.Dana-Farber Cancer Institute Why?
Mehra Golshan, M.D.Brigham and Women's Hospital Why?
Sara Michell Tolaney, M.D.Dana-Farber Cancer Institute Why?
Per Page    Page  of 231last Nextnext
Prev
Search Criteria
  • Chemotherapy Adjuvant
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.